Davis Asset Management’s Merck MRK Stock Holding History

Davis Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$514K	Hold	4,000	–	–	0.01%	48
2026 Q1	$481K	Buy	+4,000	New	+$462K	0.01%	47

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Davis Asset Management's MRK Position: Q2 2026 in Review

Davis Asset Management held its Merck (MRK) position steady in Q2 2026 at 4,000 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #48.

Davis Asset Management first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Davis Asset Management held 4,000 shares of Merck worth $514K as of Q2 2026.
Davis Asset Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.01% of Davis Asset Management's portfolio in Q2 2026, its #48 holding.
Davis Asset Management first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Davis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.